Keith Gill
"Melrose Industries represents a classic deep value opportunity where near-term operational noise obscures exceptional long-term fundamentals. The market is pricing in perpetual cash consumption when the company is demonstrably at an inflection point - H1 2025 showed £91 million FCF improvement and management confidently guides to £100m+ for the full year. The Engines division's RRSP portfolio is essentially a toll booth on global aviation, collecting royalties on ~70% of flying hours for decades to come. At ~15x forward earnings versus peers like Rolls-Royce at 41x and GE Aerospace at similar multiples, Melrose trades at a substantial discount despite comparable quality assets. Morningstar's 800p fair value estimate implies 31% upside, while the company's own 2029 targets (if achieved) suggest the stock could trade significantly higher. The wide economic moat from sole-sourced positions, design-led relationships embedded for program lifetimes, and breakthrough additive fabrication technology are not adequately reflected in the current valuation. The defense spending surge provides upside optionality not in current targets. Key risks are real but manageable, and the company's conservative balance sheet (2.0x leverage with £693m liquidity headroom) provides margin of safety. This is a patient investor's opportunity to buy a high-quality aerospace compounder before the market recognizes the cash flow transformation."
Overview
This is a deep value and contrarian analysis of Melrose Industries PLC (LSE:MRO), a UK-based aerospace and defense company that has transformed from a 'buy, improve, sell' industrial turnaround specialist into a pure-play aerospace technology business following the demerger of its automotive division (Dowlais) in 2023. The company now operates through two divisions - Engines and Structures - with design-led positions on virtually all major aircraft platforms globally. Despite strong operational progress and a clear path to significant cash flow generation, the stock trades at what appears to be a substantial discount to intrinsic value, creating a potential opportunity for patient investors willing to hold through the company's cash flow inflection point.
The Bear Case
Wall Street's skepticism centers on several legitimate concerns: First, the company has been unable to generate positive free cash flow for three consecutive years as a standalone aerospace business, with heavy restructuring costs and GTF powder metal inspection payments creating persistent cash drains. Second, the high price-to-book ratio of 273x appears alarming on the surface, suggesting limited asset backing. Third, the Structures division operates in what analysts describe as 'one of the least attractive areas of commercial aerospace' with weak pricing power and complex supply chains. Fourth, currency headwinds have forced management to revise guidance downward - the FX translation from $1.25 to $1.335 reduced operating profit guidance by £30-40 million. Fifth, UBS maintains a 'sell' rating with a price target of just 410p (vs. current 610p), arguing the Engines RRSP 'cash mountain' is worth only half of management's estimate. Finally, the stock has underperformed the UK market and aerospace peers like Rolls-Royce, which has risen over 1,285% in three years while Melrose has struggled. Supply chain disruptions and tariff uncertainty add further operational complexity.
The Bull Case
The contrarian thesis rests on several powerful but underappreciated factors: First, 2025 marks a critical inflection point - management guides to £100+ million positive free cash flow, with restructuring cash outflows ending this year. The £91 million YoY improvement in H1 2025 FCF validates this trajectory. Second, the Engines division possesses an irreplaceable portfolio of 19 Risk and Revenue Sharing Partnerships covering ~70% of global flying hours, creating a multi-decade annuity stream. Six engines (V2500, CFM56, GEnx, XWB, GTF variants) drive 90% of future RRSP value. Third, the market ignores that 17 of 19 RRSPs are already in cash-generative phase, with the problematic GTF programs expected to turn cash-positive by 2028. Fourth, over 70% of revenue is sole-sourced, creating exceptional competitive moats. Fifth, the defense spending surge - NATO targeting 5% of GDP by 2035 and Europe's €800 billion ReArm plan - provides a significant tailwind not yet reflected in 2029 targets. Sixth, management's 2029 targets of £5 billion revenue, £1.2 billion+ operating profit, and £600 million free cash flow imply massive earnings growth (>20% CAGR) with the stock trading at just ~15x forward earnings. Seventh, Morningstar assigns a WIDE economic moat and an 800p fair value estimate - 31% above current price. Finally, the company is actively returning capital through £250 million buybacks and 20% dividend growth.
Fundamental Deep Dive
Balance Sheet Strength
Net debt stands at £1,404 million with leverage of 2.0x EBITDA - well within the company's target range of 1.5-2.0x and comfortably below the 3.5x banking covenant. Liquidity is robust with £693 million headroom on committed facilities plus £121 million cash. The company has access to £2.2 billion in committed term loans and revolving credit facilities extending to 2028. Management maintains a conservative approach, targeting investment-grade metrics over time. The pension deficit is manageable at just £52 million. The balance sheet can easily support both investment in growth (additive fabrication) and shareholder returns. Going concern analysis shows no covenant breach risk even under severe downside scenarios.
Hidden Assets
The crown jewel is the RRSP portfolio with £22 billion in gross lifetime expected cash flows (£6 billion net at 7.5% discount rate) - essentially a royalty stream on global aviation. The company's design-led positions are deeply embedded in aircraft programs for 30+ years, creating switching costs that competitors cannot overcome. The additive fabrication technology, where Melrose is the only company with a certified additively manufactured structural component flying today, represents significant hidden value with GE alone committing £5 billion in contracts. The 32 manufacturing sites represent operational infrastructure built over decades. Brand relationships with all major engine OEMs (Pratt & Whitney, GE, Rolls-Royce, Safran) are irreplaceable.
Revenue Stability
Revenue demonstrates exceptional stability with long-term program visibility. Commercial aviation backlogs extend 8-9 years with ~15,000 aircraft on order. Defense contracts provide multi-year visibility (85% of portfolio now sustainably priced). The aftermarket business grows with flight hours (6% CAGR expected to 2030), providing counter-cyclical revenue. RRSP variable consideration alone was £182 million in H1 2025. The company has content on virtually every commercial flight globally - civil aerospace at 72% of revenue and defense at 28% provides diversification. Revenue grew 6% in H1 2025 despite supply chain headwinds, demonstrating resilience.
Sentiment & Technical Setup
Short Interest
Short interest data is not available for UK-listed securities in the same format as US stocks. However, the stock's 62% rise from its 52-week low of 376p to current levels of 610p suggests any short positions have been squeezed. The stock trades 10.6% below its 52-week high of 682.6p, indicating recent consolidation rather than capitulation. The 50-day moving average at 595p and 200-day at 543p both sit below the current price, confirming the uptrend. Average daily volume of ~3 million shares provides adequate liquidity.
Institutional Positioning
The stock is covered by 30 analysts with Morningstar assigning a wide economic moat and 5-star rating (significantly undervalued). Institutional views are mixed - the Investors Chronicle recommendation is Buy at 612p. UBS maintains a sell rating at 410p target, while Barclays and others appear more constructive. Alphyn Capital, a value-focused fund, highlights Melrose as a key holding, noting the market's excessive skepticism about cash generation. The departure of the original Melrose founders (Peckham, Martin, Miller) in 2024 concerned some investors but the new management team under Peter Dilnot has executed well on the transformation plan.
Retail Sentiment
Retail sentiment appears cautiously optimistic. Motley Fool UK analysts describe Melrose as their 'personal sector preference' over Rolls-Royce, highlighting the valuation disconnect (16x forward P/E vs Rolls-Royce at 41x). Simply Wall St shows the stock trading 12% below fair value estimates. Social commentary focuses on the dramatic underperformance versus Rolls-Royce despite similar exposures, with investors questioning whether Melrose could experience a similar re-rating once cash flow inflection is proven. The narrative that 'cash is king' and Melrose hasn't generated positive FCF resonates with skeptics but may be about to change.
Catalyst Analysis
Multiple catalysts could drive a re-rating: 1) Q4 2025 results (February 2026) should confirm £100m+ free cash flow achievement - the first positive FCF year as a standalone company. 2) Completion of restructuring program by year-end 2025 eliminates a major cash drain. 3) GTF powder metal resolution progressing well, with headwinds expected to fade in 2027 and programs turning cash-positive in 2028. 4) Defense spending surge from NATO/European rearmament not yet in 2029 targets - provides upside optionality. 5) Additive fabrication commercialization accelerating - 100% serial production on Fan Case Mount Ring by end-2025, with a growing pipeline of parts to certify. 6) Continued execution on 85% defense repricing achievement demonstrates management credibility. 7) Potential strategic review of Structures division could unlock value - Senior recently received a 'surprisingly generous payment' for its structures business. 8) Ongoing £250 million share buyback (£150 million remaining) provides price support. 9) Dividend growth of 20% annually signals confidence. 10) Any evidence of accelerating OEM production rates would boost sentiment.
Key Risks
Primary Risk
Execution failure on cash flow inflection - if 2025 free cash flow disappoints or restructuring costs extend, the narrative of perpetual cash consumption could persist, keeping the stock depressed. The market has been burned before by management guidance.
Secondary Risks
- Prolonged supply chain disruptions impacting OEM build rates and Melrose's ability to deliver revenue growth
- Currency volatility - a 1% USD move impacts operating profit by £6 million; stronger sterling has already forced guidance revisions
- GTF powder metal issues lasting longer or costing more than expected (currently ~£70m/year through 2026)
- Structures division margin improvement stalling, validating bear case that it's a low-quality asset
- Broader aerospace cycle downturn if air travel demand weakens or defense budgets face political pressure
- New tariff implementations beyond current mitigation measures
What Would Change My Mind
I would reassess the bullish thesis if: 1) 2025 free cash flow comes in below £50 million or negative; 2) Management pushes out 2029 targets or significantly reduces them; 3) RRSP variable consideration growth stalls or declines; 4) The Structures division fails to reach 9% margins by year-end 2025; 5) Leverage rises above 2.5x without clear justification; 6) Key management departures occur; 7) Major customer (Airbus/Boeing) significantly cuts production forecasts; 8) Additive fabrication certification pipeline stalls or competitors emerge with similar capabilities.
Conclusion
Melrose Industries represents a classic deep value opportunity where near-term operational noise obscures exceptional long-term fundamentals. The market is pricing in perpetual cash consumption when the company is demonstrably at an inflection point - H1 2025 showed £91 million FCF improvement and management confidently guides to £100m+ for the full year. The Engines division's RRSP portfolio is essentially a toll booth on global aviation, collecting royalties on ~70% of flying hours for decades to come. At ~15x forward earnings versus peers like Rolls-Royce at 41x and GE Aerospace at similar multiples, Melrose trades at a substantial discount despite comparable quality assets. Morningstar's 800p fair value estimate implies 31% upside, while the company's own 2029 targets (if achieved) suggest the stock could trade significantly higher. The wide economic moat from sole-sourced positions, design-led relationships embedded for program lifetimes, and breakthrough additive fabrication technology are not adequately reflected in the current valuation. The defense spending surge provides upside optionality not in current targets. Key risks are real but manageable, and the company's conservative balance sheet (2.0x leverage with £693m liquidity headroom) provides margin of safety. This is a patient investor's opportunity to buy a high-quality aerospace compounder before the market recognizes the cash flow transformation.
Research Sources (22 found)
Melrose Industries (LON:MRO) Stock Price & Overview
Published: 8/14/2025
Melrose 2025 Half Year Results
Published: 8/1/2025
Melrose Industries (LSE:MRO) - Stock Analysis
Published: 10/1/2025
melrose-2025-half-year-results-announcement-final.pdf
Published: 8/1/2025
I expect this stock to grow faster than the Rolls-Royce ...
Published: 7/16/2025
HY2025 Results Presentation - Melrose Industries
Published: 8/1/2025
Which UK Mid-Cap Stocks Are Undervalued?
Published: 12/17/2025
What is Melrose Industries' Growth Strategy?
Published: 11/25/2025
Melrose Industries PLC, MRO:LSE summary - FT.com
Published: 12/20/2025
Aerospace Parts Manufacturing Market Size, Share & 2030 ...
Published: 9/16/2025
Melrose shares up 8% on upgrade as founders depart after strategy shift
Published: 9/11/2025
Investors to cash-in with Melrose - eyes future shareholder returns
Published: 9/11/2025
Melrose shares up 8% on u00a3500 million buyback plan
Published: 9/10/2025
Transaction in Own Shares | Company Announcement | Investegate
Published: 9/10/2025
Melrose shares up 7% after keeping full-year profit guidance
Published: 9/11/2025
Nov 25 Trading Update_RNS 141125
Published: 11/14/2025
Melrose (Trading Update): full-year guidance on track
Published: 11/14/2025
Melrose Industries update not likely to move dial, says UBS
Published: 9/30/2025
Melrose Industries 4-Month Revenues, Operating Profit Rise; Confirms FY25 Outlook
Published: 11/14/2025
Melrose backs guidance as Engines arm drives double-digit sales growth
Published: 11/14/2025
Letter to investors, Q3 2025 Performance As reported by ...
Published: 10/29/2025
Here's the latest Rolls-Royce share price forecast
Published: 9/11/2025
Search Queries Generated
Melrose Industries PLC MRO earnings per share revenue growth margins guidance 2024
Melrose Industries PLC competitive position market share aerospace defense competitors
Melrose Industries PLC CEO strategy capital allocation shareholder returns insider buying
Melrose Industries PLC risks concerns challenges bear case problems headwinds
Melrose Industries PLC aerospace defense industry trends catalysts regulatory impact
William O'Neil
"Melrose aligns well with CAN SLIM: accelerating quarterly EPS and margin expansion (C), improving annual earnings and a credible 5-year profit/FCF roadmap (A), multiple new product/technology and contract catalysts plus recent new highs (N), buybacks and strong platform demand (S), leadership characteristics and relative strength (L), robust institutional coverage (I), and a favorable sector trend despite macro crosswinds (M). Risks—tariffs/supply chain, GTF remediation cash flow, and leverage ~2.0x—are acknowledged but manageable with mitigations in place and cash generation inflecting in 2025. Tactically, consider adding on a constructive pullback toward the 50-day (~607p) or on a high-volume breakout above ~683p in line with O’Neil’s rules."
Overview
This report analyzes Melrose Industries PLC (LSE:MRO), an aerospace and defense Tier‑1 supplier, using William J. O’Neil’s CAN SLIM framework. It synthesizes the latest company-reported results and guidance with market data to assess growth, quality, and timing for investors.
Financial and Business Overview
Business model: Melrose is now a pure-play global aerospace and defense technology group operating through two divisions: Engines (risk-and-revenue-sharing partnerships, non-RRSP OE, repairs, and governmental) and Structures (design-to-build aerostructures, EWIS, transparencies). It is a ‘Super-Tier 1’ partner with embedded, often sole-source positions across leading civil and defense platforms. Scale and profitability: 2025 guidance (at $/£ 1.335) calls for £3.425–£3.575bn revenue and £620–£650m adjusted operating profit with Group margins ~18% for 2025; H1 2025 adjusted operating profit rose 29% YoY to £310m with margin up 380 bps to 18.0% (Engines margin 33.4%, Structures 6.7%). Adjusted diluted EPS in H1 2025 was 15.1p (+30% YoY). Cash and leverage: Free cash flow is guided to £100m+ for 2025; H1 free cash outflow improved by £91m to £54m due to higher earnings and lower restructuring. Net debt at 30 June 2025 was £1.404bn (2.0x ND/EBITDA), within covenant headroom. Buybacks of £250m are underway (c.£91m completed by H1 2025). Balance sheet snapshot (FY 2024): Total assets £7.44bn, liabilities £4.59bn, equity £2.84bn; book value per share ~£2.21. Working capital was negative (FY 2024 working capital -£171m) reflecting typical aero program cash dynamics and customer advances. Valuation and trading: Price 634.6p (GBp), trailing P/E ~25.4x on TTM EPS ~25p; P/B ~2.9x (price ~£6.35 vs book ~£2.21). Dividend ~6.0p (≈1% yield). Average analyst rating: Buy.
Market Position & Competitive Advantages
Position: Embedded, life-of-program content across 19 engine RRSPs (≈70% of global flight hours coverage) plus broad Structures content with >70% sole-source civil/defense positions. Structural tailwinds include record civil backlogs (narrowbody/widebody) and accelerated defense outlays (NATO/EU), driving OE ramps and aftermarket growth for decades. Moats and advantages: - High switching costs: Design-led, certified content integrated into platforms for program life. - Aftermarket annuity: Mature engines (e.g., V2500, CFM56) plus growing fleets (GEnx, XWB, GTF) provide multi-decade cash flows; Engines margin already >33%. - Technology leadership: Breakthrough additive fabrication (first and only certified major structural engine component in serial transition by end-2025), participation in next-gen engines (CFM RISE, next-gen GTF), and advanced composites/EWIS. - Operational transformation: Multi-year footprint consolidation (52 to 32 sites), repricing (85% of defense portfolio sustainably repriced 6 months early), lean ‘Brilliant Basics’ driving safety/quality/productivity gains. Key risks (be honest): - Tariffs/supply chain: US tariff regime and aerospace casting/forging constraints create complexity and working capital friction (mitigations in place but residual risk persists). - Concentration & program risk: GTF powder metal remediation costs (~£70m in 2025/26) and pacing of OE build rates can affect variable consideration timing and cash flows. - Leverage and cash conversion: Leverage ~2.0x; FCF inflects in 2025 but remains modest this year; variable consideration accounting and negative working capital require disciplined execution. - Governance optics: Shareholders rejected the directors’ remuneration report at the 2025 AGM (non-binding), highlighting sensitivity to pay alignment.
Stock Performance
Price: 634.6p; 52-week range 376p–682.6p; currently ~7% below the 52-week high and ~35% above the 52-week low. 50-day average ~607p; 200-day average ~542p, indicating an established uptrend. One-year total price change ~+34.9%. Average daily volume ~3.6m shares. The share has been resilient on improving margins, clearer cash inflection, and buyback support, with episodic volatility around tariff headlines and FX.
CAN SLIM Analysis
Current Quarterly Earnings Per Share (EPS) Growth:
C: Strong. H1 2025 adjusted diluted EPS rose ~30% YoY to 15.1p, driven by Engines aftermarket and margin expansion (Engines margin +400 bps to 33.4%). Adjusted operating profit +29% YoY. Data points: H1 2025 EPS 15.1p vs 11.9p; Group margin 18.0% (+380 bps). Supports the C criterion.
Annual Earnings Increases:
A: Improving trend. 2024 adjusted diluted EPS 26.4p; 2025 continues to track profit growth with unchanged operating profit guidance (constant FX). Street sources show EPS rising from ~0.17–0.20 in 2023/2024 to ~0.33 projected for 2025. Five-year targets: revenue to >£5bn by 2029, operating profit >£1.2bn (24%+ margin), FCF ~£600m. While statutory EPS was affected by legacy charges, adjusted EPS trajectory is up and to the right. Overall positive for A.
New Products, Management, or Price Highs:
N: Multiple ‘new’ catalysts. Technology: additive fabrication in serial transition (Fan Case Mount Ring on PW1500G to 100% additive by end-2025), next-gen propulsion (CFM RISE, next-gen GTF), expanded defense (Gripen RM16, Typhoon canopies extension), Ariane 6 components. Governance: new Chair (Chris Grigg) and new RemCo Chair (Alison Goligher) in 2025. Technical: shares printed a 52-week high at 682.6p, indicating institutional demand on new-margin narrative. Strong N.
Supply and Demand:
S: Favorable float dynamics. Ongoing £250m buyback (≈£91m completed by H1 2025) reduces supply; average 3.6m shares/day liquidity is ample for institutions. Shares outstanding ~1.26bn. Fundamental supply/demand: record aero backlogs and rising military budgets underpin multi-year demand for Melrose content. Risk: tariff waves and supply chain constraints can shift near-term delivery timing and working capital. Net effect supportive.
Leader or Laggard:
L: Leader. Relative strength: +35% 52-week price performance vs FTSE 100 single digits; sector leadership through high-margin Engines aftermarket and additive tech. Engines operating margin >33% and rising, outpacing many aero suppliers. Stock trades above 50- and 200-day MAs with prior new highs—classic leadership behavior.
Institutional Sponsorship:
I: Solid and improving. FTSE 100 constituent with broad institutional coverage and a consensus Buy rating. Continued buybacks, insider alignment (Chair share purchases were reported), and clear capital framework (progressive dividend + buybacks) appeal to institutions. Note: 2025 AGM saw a vote against the remuneration report (non-binding), so governance scrutiny remains. Overall, institutional sponsorship criterion is met.
Market Direction:
M: Mixed-to-positive. Broader markets have been volatile on tariff/FX headlines, but aerospace/defense remains in a cyclical uptrend with strong earnings revisions and defense rearmament. CAN SLIM discipline suggests prioritizing entries on breakouts or pullbacks during market strength; Melrose is in an established uptrend, with sector wind at its back though macro remains choppy.
Conclusion
Melrose aligns well with CAN SLIM: accelerating quarterly EPS and margin expansion (C), improving annual earnings and a credible 5-year profit/FCF roadmap (A), multiple new product/technology and contract catalysts plus recent new highs (N), buybacks and strong platform demand (S), leadership characteristics and relative strength (L), robust institutional coverage (I), and a favorable sector trend despite macro crosswinds (M). Risks—tariffs/supply chain, GTF remediation cash flow, and leverage ~2.0x—are acknowledged but manageable with mitigations in place and cash generation inflecting in 2025. Tactically, consider adding on a constructive pullback toward the 50-day (~607p) or on a high-volume breakout above ~683p in line with O’Neil’s rules.
Research Sources (21 found)
Results, reports and presentations
Published: 6/23/2025
Melrose Industries (LON:MRO) Has A Somewhat Strained Balance Sheet
Published: 5/2/2025
Melrose Industries (LON:MRO) Balance Sheet
Published: 5/15/2025
Does Melrose Industries (LON:MRO) Have A Healthy Balance Sheet?
Published: 5/2/2025
Annual Report & Statements - Melrose Industries plc (MRO)
Published: 5/14/2025
Melrose 2025 Half Year Results - 1 August 2025 Transcipt
Published: 8/4/2025
Melrose Industries PLC (MRO.L): Navigating The Aerospace Market With Strategic Precision
Published: 9/1/2025
Melrose Industries PLC (MRO.L): A Strategic Look At Valuation, Performance, And Growth Potential
Published: 6/9/2025
Investegate | Company Announcement
Published: 5/14/2025
Investors rush to back new Melrose deal
Published: 9/10/2025
Melrose shares up 8% on upgrade as founders depart after strategy shift
Published: 9/11/2025
Melrose tops FTSE 100 risers with trading ahead of expectations
Published: 9/10/2025
Melrose Industries PLC (MRO) - Market News
Published: 5/20/2025
Windfall hopes for Melrose
Published: 9/11/2025
Melrose Industries PLC Company Financials and Reports | MRO | GB00BNGDN821
Published: 5/14/2025
Latest news about Melrose Industries PLC - MarketScreener UK
Published: 5/15/2025
Melrose Industries share price | MRO | News
Published: 5/14/2025
Melrose Industries share price | MRO | Financials
Published: 5/15/2025
melrose-2025-half-year-results-announcement-final.pdf
Published: 8/1/2025
Across The Markets
Published: 10/27/2025
Market News & Investing Advice
Published: 9/5/2025
Search Queries Generated
Melrose Industries plc MRO financial health CAN SLIM earnings growth debt levels liquidity metrics
Melrose Industries plc MRO market position leadership in metal engineering sector relative to peers and industry group strength
Melrose Industries plc MRO recent news acquisitions debt restructuring news catalysts and implications for stock
Melrose Industries plc MRO competitive risks supplier concentration competitive dynamics and margin pressures
Melrose Industries plc MRO market share trends debt burden acquisition challenges and cash flow pressures